2026 IKCS: North America
November 19 – November 21
Transforming Kidney Cancer Research
The Kidney Cancer Association is proud to host the 2026 International Kidney Cancer Symposium (IKCS): North America. IKCS meetings are dynamic, multidisciplinary events that explore current trends and future directions in kidney cancer. Our community includes leading experts across academia, clinical care, industry, and advocacy who are committed to exchanging innovative ideas and pushing boundaries to advance kidney cancer care.
Date: November 19-21, 2026
Location: Dallas, Texas
Meeting Hotel: Renaissance Dallas Hotel
Publications
To come
Important Dates
| Abstract Submissions Open | July 10, 2026 |
| Registration Open | TBD |
| Abstract Submission Deadline (all complete Regular, TPS, and Case Report submissions, and all LBA Placeholders due at this time) | August 28, 2026 |
| Early Registration Deadline | October 29, 2026 |
| Hotel Cancellation Deadline | October 27, 2026 |
| 2026 IKCS: North America | November 19-21, 2026 |
Email [email protected] with questions about fees and cancellation policies.
2026 IKCS: North America Scientific Planning Committee
Dr. Laura Bukavina
Co-Chair
Cleveland Clinic
Dr. Dan Geynisman
Co-Chair
Fox Chase Cancer Center
Dr. Qing Zhang
Co-Chair
UT Southwestern Medical Center
Dr. Stephanie Berg
Dana-Farber Cancer Institute
Dr. Manoj Bupathi
Sarah Cannon Research Institute
Dr. Arpita Desai
UC San Francisco
Dr. Amy Luckenbaugh
Vanderbilt University
Dr. Viraj Master
Emory University
Dr. Sarah Psutka
University of Washington
Virginia Seery, RN, MSN
Beth Israel Deaconess Medical Center
Dr. Chad Tang
MD Anderson Cancer Center
Dr. Martin Voss
Memorial Sloan Kettering Cancer Center